Matches in SemOpenAlex for { <https://semopenalex.org/work/W2596459085> ?p ?o ?g. }
- W2596459085 endingPage "517" @default.
- W2596459085 startingPage "507" @default.
- W2596459085 abstract "Abstract Metastatic breast cancer (MBC) results in substantial morbidity and mortality for women afflicted with this disease. A majority of MBCs are hormone-responsive and estrogen receptor-positive, making endocrine therapy (ET) an integral component of systemic therapy. With a primary goal of minimizing the effects of estrogen on hormone-responsive MBC, ETs are among the first targeted treatments that aim to inhibit the influence of estrogen receptor activation on tumor proliferation. Several biochemical mechanisms have been the focus of drug development for treatment, including selective estrogen-receptor modulation, aromatase inhibition, and selective estrogen-receptor degradation. Treatments that exploit these mechanisms have improved survival and quality of life for women with MBC. However, in many cases, resistance to ET limits their effectiveness. Elucidation of the complex cellular signal cascades involved in the development of acquired resistance to ET and the interrelationship of growth factor signaling and estrogen responsiveness have characterized components of these pathways as attractive targets for drug development. Based on these insights and with the aim of overcoming hormone resistance, targeted therapies are emerging as useful treatments for MBC. This article reviews current endocrine treatments of MBC as well as recent and ongoing study of combination treatments and targeted therapies that interfere with cellular proliferation pathways as means of overcoming resistance." @default.
- W2596459085 created "2017-03-23" @default.
- W2596459085 creator A5047918797 @default.
- W2596459085 creator A5085028425 @default.
- W2596459085 date "2017-03-17" @default.
- W2596459085 modified "2023-09-23" @default.
- W2596459085 title "Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer" @default.
- W2596459085 cites W120187336 @default.
- W2596459085 cites W1245681932 @default.
- W2596459085 cites W1453600927 @default.
- W2596459085 cites W1464936406 @default.
- W2596459085 cites W1489721537 @default.
- W2596459085 cites W1508224111 @default.
- W2596459085 cites W1536583711 @default.
- W2596459085 cites W1565310327 @default.
- W2596459085 cites W1578397235 @default.
- W2596459085 cites W1588388541 @default.
- W2596459085 cites W1605523334 @default.
- W2596459085 cites W1829077072 @default.
- W2596459085 cites W1839333839 @default.
- W2596459085 cites W1848530042 @default.
- W2596459085 cites W1861295276 @default.
- W2596459085 cites W1918073772 @default.
- W2596459085 cites W1932574503 @default.
- W2596459085 cites W1963505593 @default.
- W2596459085 cites W1986757639 @default.
- W2596459085 cites W1990883066 @default.
- W2596459085 cites W1991070664 @default.
- W2596459085 cites W1991981105 @default.
- W2596459085 cites W1993837674 @default.
- W2596459085 cites W1995916005 @default.
- W2596459085 cites W1997224885 @default.
- W2596459085 cites W2001652125 @default.
- W2596459085 cites W2014001512 @default.
- W2596459085 cites W2018342610 @default.
- W2596459085 cites W2022102157 @default.
- W2596459085 cites W2024415595 @default.
- W2596459085 cites W2025215722 @default.
- W2596459085 cites W2025883768 @default.
- W2596459085 cites W2029055202 @default.
- W2596459085 cites W2031131661 @default.
- W2596459085 cites W2031350877 @default.
- W2596459085 cites W2032144589 @default.
- W2596459085 cites W2033672070 @default.
- W2596459085 cites W2040512792 @default.
- W2596459085 cites W2041799604 @default.
- W2596459085 cites W2043054566 @default.
- W2596459085 cites W2044165142 @default.
- W2596459085 cites W2044658427 @default.
- W2596459085 cites W2046794494 @default.
- W2596459085 cites W2055091445 @default.
- W2596459085 cites W2077773619 @default.
- W2596459085 cites W2082717946 @default.
- W2596459085 cites W2084370215 @default.
- W2596459085 cites W2085133181 @default.
- W2596459085 cites W2088902203 @default.
- W2596459085 cites W2093749264 @default.
- W2596459085 cites W2095092592 @default.
- W2596459085 cites W2098270787 @default.
- W2596459085 cites W2102620699 @default.
- W2596459085 cites W2102685625 @default.
- W2596459085 cites W2103063413 @default.
- W2596459085 cites W2104561097 @default.
- W2596459085 cites W2106036365 @default.
- W2596459085 cites W2109315042 @default.
- W2596459085 cites W2109617076 @default.
- W2596459085 cites W2113458582 @default.
- W2596459085 cites W2115950635 @default.
- W2596459085 cites W2117301449 @default.
- W2596459085 cites W2117357260 @default.
- W2596459085 cites W2119609398 @default.
- W2596459085 cites W2122929031 @default.
- W2596459085 cites W2123006593 @default.
- W2596459085 cites W2124947719 @default.
- W2596459085 cites W2126970578 @default.
- W2596459085 cites W2129958055 @default.
- W2596459085 cites W2132180344 @default.
- W2596459085 cites W2133667885 @default.
- W2596459085 cites W2138692147 @default.
- W2596459085 cites W2139726760 @default.
- W2596459085 cites W2139955290 @default.
- W2596459085 cites W2140084692 @default.
- W2596459085 cites W2141647078 @default.
- W2596459085 cites W2142334766 @default.
- W2596459085 cites W2144790402 @default.
- W2596459085 cites W2146778486 @default.
- W2596459085 cites W2147428098 @default.
- W2596459085 cites W2151082560 @default.
- W2596459085 cites W2157333957 @default.
- W2596459085 cites W2160584021 @default.
- W2596459085 cites W2165819904 @default.
- W2596459085 cites W2165999332 @default.
- W2596459085 cites W2167188058 @default.
- W2596459085 cites W2170908060 @default.
- W2596459085 cites W2202169216 @default.
- W2596459085 cites W2235523093 @default.
- W2596459085 cites W2243467818 @default.
- W2596459085 cites W2258559299 @default.